Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHA:688488)

China · Delayed Price · Currency is CNY

15.80

-0.52 (-3.19%)

Sep 2, 2026, 3:00 PM CST

SHA:688488 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	722.54	719.17	417.8	411.36	244.22	255.71
Revenue Growth	20.58%	72.13%	1.57%	68.44%	-4.49%	-11.54%
Gross Profit	465.21	463.34	193.28	166.36	72.04	74.38
Operating Income	59.39	34.76	-142.11	-106.03	-171.64	-62.34
Net Income	-5.79	-19.53	-141.2	-76.07	-124.09	-29.99
Earnings Per Share	-0.01	-0.05	-0.34	-0.18	-0.30	-0.07
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
Biomedical Raw Materials	57.84
Pharmaceutical Manufacturing	660.33
Total	718.18

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	487.46	451.35	441.52	441.1	486.54	606.02
Total Debt	748.31	559.15	488.03	412.3	208.77	5.59
Net Cash (Debt)	-260.85	-107.8	-46.5	28.8	277.78	600.43
Net Cash Growth	-	-	-	-89.63%	-53.74%	-23.12%
Net Cash Per Share	-0.62	-0.26	-0.11	0.07	0.67	1.40

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	18.24	17.63	-37.5	-166.22	-92.55	-12.37
Capital Expenditures	-58.06	-47.93	-44.56	-71.2	-140.3	-94.78
Free Cash Flow	-39.82	-30.3	-82.06	-237.43	-232.85	-107.15
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	64.39%	64.43%	46.26%	40.44%	29.50%	29.09%
Operating Margin	8.22%	4.83%	-34.01%	-25.78%	-70.28%	-24.38%
Pretax Margin	4.03%	3.43%	-39.73%	-22.39%	-58.30%	-16.53%
Profit Margin	-0.80%	-2.72%	-33.80%	-18.49%	-50.81%	-11.73%
FCF Margin	-5.51%	-4.21%	-19.64%	-57.72%	-95.34%	-41.90%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	145.16	-	-	-	-
PS Ratio	9.20	9.56	7.92	12.80	18.13	25.57